You will receive a pathology referral by SMS. Take it to any pathology clinic.
Everything you need to know about BV testing in Australia
What this page covers. Bacterial vaginosis (BV) is one of the most common causes of vaginal discharge and odour in women, affecting around 30 percent of Australian women at any time. It is not strictly a sexually transmitted infection but the testing pathway sometimes overlaps with STI testing because symptoms can be similar to trichomoniasis. This page covers what a BV test involves, how the modern molecular tests differ from the older clinical criteria, when testing is appropriate, what positive and negative results mean, and how recurrent BV is managed.
What BV actually is. Bacterial vaginosis is not a single-bacterium infection. It is an imbalance in the normal vaginal bacteria, where lactobacilli (the normal "good" bacteria) decrease and a mixed population of anaerobic bacteria (mainly Gardnerella, Atopobium, Prevotella and others) takes over. The vaginal pH rises above 4.5 as a result. The classic symptoms are a thin grey or white discharge with a fishy odour, especially after sex or during menstruation. Around half of women with BV have no symptoms at all.
BV is not strictly a sexually transmitted infection. BV is more common in sexually active women and certain sexual practices increase the risk, but it can occur in women who have never been sexually active. The reason BV is sometimes confused with an STI is that the symptoms (discharge, odour) overlap with trichomoniasis, and that women presenting with vaginitis symptoms often have STI testing done as part of the workup. The bacteria that cause BV are different from the bacteria that cause STIs — chlamydia, gonorrhoea, and trichomoniasis are diagnosed by separate tests.
How BV is traditionally diagnosed. The traditional diagnosis uses the Amsel criteria: at least three of four clinical features must be present. The four are: a thin homogeneous discharge, a positive whiff test (a fishy odour when potassium hydroxide is added to the discharge), an elevated vaginal pH (above 4.5), and the presence of clue cells (vaginal epithelial cells coated with bacteria) on a wet-mount slide under the microscope. Amsel criteria are still used in some sexual health clinics where wet-mount microscopy is available at the point of care.
Modern molecular BV testing. The newer approach is a molecular panel that measures the specific bacteria in the vaginal sample and reports a BV-positive or BV-negative result based on the pattern. Some panels also test for trichomoniasis and candida at the same time. The molecular approach has higher sensitivity than wet-mount microscopy and does not require the lab to look at the sample under a microscope. The sample is a self-collected vaginal swab. Results return in 2 to 4 business days.
When BV testing is appropriate. Australian guidelines support BV testing for women with vaginitis symptoms (discharge, fishy odour, irritation), women with recurrent symptoms despite previous treatment, women being assessed for pelvic inflammatory disease, and women in pregnancy with symptoms (because untreated BV in pregnancy is associated with preterm birth). Routine screening of women without symptoms is not recommended.
How the sample is collected. A self-collected vaginal swab is the standard for the molecular BV test. The swab is inserted into the vagina, rotated for a few seconds, and removed — you do not need to reach far in. The swab is then placed in the collection tube and taken to the pathology lab. The Specialist GP sends a referral by SMS after the consult. See pathology collection centres for major collection options.
A positive result. The Specialist GP calls to discuss the result and the treatment pathway. See BV treatment for the full clinical detail. Treatment is usually a short course of either oral or vaginal antibiotic medication. The alcohol-interaction rule applies to some BV regimens (similar to trichomoniasis treatment) but not all.
A negative result. A negative BV test in someone with vaginitis symptoms suggests another cause — trichomoniasis, candida (thrush), atrophic vaginitis (in postmenopausal women), allergic or irritant contact reactions, or less common conditions. The Specialist GP can arrange further testing or in-person review at the East Melbourne clinic depending on what is most likely.
BV and trichomoniasis often co-occur. Around 15 to 20 percent of women with BV also have trichomoniasis. When both are present, both are usually treated. The trichomoniasis treatment medication can sometimes treat BV as well, but a separate BV-specific course is often needed. Combined BV + trichomoniasis testing on a single sample is the standard when both are being considered. See trichomoniasis testing for the parasite-specific detail.
Recurrent BV. BV recurrence is common — more than half of women treated for BV will have a recurrence within 12 months. The diagnostic approach to recurrent BV is similar to one-off BV (molecular test on vaginal swab) but the management focuses on identifying and addressing triggers (sexual practices, douching, hygiene products, intrauterine devices in some cases) and considering longer-term prevention strategies. The Specialist GP can discuss these at the consult.
What "clue cells" actually are. Clue cells are vaginal epithelial cells (the surface cells that line the vagina) that have been coated with bacteria. Under the microscope, the edges of the cells look fuzzy or stippled instead of smooth, hence the name — they are a "clue" to the diagnosis. Seeing clue cells on a wet-mount slide is one of the Amsel criteria. In practice, the modern molecular tests have largely replaced wet-mount microscopy because they are more sensitive, do not require the lab to do microscopy in real time, and can be performed on a self-collected swab.
Why fishy odour is the classic BV symptom. The fishy odour comes from volatile amines (chemicals) produced by the anaerobic bacteria that take over in BV. The odour is more noticeable in alkaline conditions, which is why it becomes more obvious after sex (semen is alkaline) and during menstruation (menstrual blood is also alkaline). The "whiff test" in the Amsel criteria uses potassium hydroxide (alkali) to bring out this odour from a sample of discharge. If you have a discharge that smells fishier after sex specifically, BV is high on the list of likely causes.
BV in pregnancy. BV in pregnancy is associated with preterm birth, premature rupture of membranes, and low birth weight. Testing is appropriate for symptomatic women during pregnancy. Treatment in pregnancy is safe and uses pregnancy-compatible regimens. The Specialist GP coordinates with your maternity team for any treatment.
STI testing alongside BV. When BV symptoms overlap with possible STI symptoms, an STI screen is often appropriate at the same time. A single vaginal swab can usually cover BV, trichomoniasis, chlamydia, and gonorrhoea testing. The Specialist GP discusses what to send based on your symptoms and sexual history. See chlamydia and the 5-infection STI screen for the broader panel. For window-period timing, see when to test after exposure.
Confidentiality. BV testing is confidential like any other consultation. BV is not a notifiable infection so there is no public health reporting required.
Want to discuss your situation? A Specialist GP phone consult can discuss whether BV testing is appropriate, what testing makes sense given your symptoms, and what to expect. See the hero section above for booking. For Melbourne residents, see BV testing in Melbourne. For the broader screening context, see the comparison of STI tests.
Frequently asked questions
Not sure what you have? Compare symptoms side by side in our STI Comparison Guide — plain English, no jargon.
Not sure when to test? See our When to Get an STI Test guide — how long after exposure to test, testing frequency, and what to do after exposure.
Strictly speaking, no. BV is an imbalance in the normal vaginal bacteria, where the usual lactobacilli decrease and anaerobic bacteria take over. It is more common in sexually active women and certain sexual practices increase the risk, but it can also occur in women who have never been sexually active. BV is sometimes confused with an STI because the symptoms overlap with trichomoniasis (discharge, fishy odour) — but the bacteria that cause BV are different from STI bacteria.
The newer molecular tests have higher sensitivity than the older wet-mount microscopy approach — they detect cases that would have been missed clinically. They also do not require the lab to look at the sample under the microscope, which makes the test more practical at standard pathology providers. The trade-off is cost: the molecular test fee may be higher than basic microscopy. The Specialist GP discusses which approach makes sense at the consult.
Yes — that pattern is one of the classic presentations of BV. The fishy odour from BV becomes more noticeable after sex because semen is alkaline, which brings out the volatile amines produced by the BV bacteria. A vaginal swab for BV (with trichomoniasis testing on the same sample) is the standard approach. The Specialist GP can arrange this on a phone consult.
Sometimes, but a test is usually preferred because: BV symptoms overlap with other causes of vaginitis (trichomoniasis, candida, atrophic vaginitis), the bacteria pattern can change between episodes, and confirming BV before treatment is more reliable than self-diagnosis. For women with frequent recurrent BV who have a well-established pattern, the Specialist GP may sometimes prescribe based on symptoms alone — this is discussed at the consult.
Self-collected vaginal swab is the standard sample for the molecular BV test, so the collection part can be done at home. The swab is then taken to a pathology collection centre for processing. Some pathology providers accept the sample by post for routine testing, though same-day drop-off is more reliable. The Specialist GP sends the referral by SMS after the consult and discusses the practical options.
Typically 2 to 4 business days for the molecular test, depending on the pathology provider. Some providers process samples on specific days of the week which can add a day or two. If the result is urgent (severe symptoms in pregnancy, for example), the Specialist GP can sometimes have the result expedited.
A clinical diagnosis (based on history and examination findings) is reasonable for an initial BV presentation in a woman with classic symptoms (thin discharge, fishy odour, no STI risk factors). The Amsel criteria are still used in some sexual health clinics. A test becomes more important when symptoms recur, when BV has failed to clear after treatment, when there are other risk factors that make trichomoniasis or another cause possible, or when the symptoms are atypical.
Not routinely as part of antenatal screening in most parts of Australia. If you have vaginitis symptoms during pregnancy, testing is appropriate because untreated BV in pregnancy is associated with preterm birth and other complications. Treatment in pregnancy is safe and uses pregnancy-compatible regimens. The Specialist GP coordinates with your maternity team if any treatment is given.
Not automatically — the molecular BV panel tests for the BV-associated bacteria but does not cover chlamydia or gonorrhoea. However, a single vaginal swab can usually cover BV, trichomoniasis, chlamydia, and gonorrhoea testing if all are sent at once. The Specialist GP discusses what to include based on your symptoms and sexual history.
The pathology lab fee for BV testing has a Medicare item number that applies in specific situations (symptomatic presentations, recurrent BV, pregnancy with symptoms). The newer molecular panels may have a separate fee depending on the pathology provider. See our fees page for Clinic365 consult fees, and the Specialist GP can confirm the pathology fee structure at booking.
